Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Calgary

$150,000.00

Chondroitin sulfate proteoglycans in multiple sclerosis

EF 2015-16

Résumé
Multiple sclerosis is the major cause of non-traumatic neurological disability in young adults in Europe and North America. According to the Multiple Sclerosis Society of Canada website, over 100,000 Canadians are living with MS. MS impacts people in their most productive years; most people with MS have onset in their twenties and thirties. The inability of current MS therapies to halt the progression or reverse the chronic disabilities of MS emphasize the importance of developing new therapies to mitigate the abnormal immune responses and prevent irreversible disability. In MS, the protective membrane that wraps around axons in the brain and spinal, known as the myelin sheath, is destroyed by the immune system. It is currently unknown what causes immune cells to invade the brain and attack the myelin. Without the myelin sheath, axons degenerate, leading to worsening neurological disability. In MS there are also widespread changes in the extracellular matrix (ECM), a network of molecules involved in maintaining brain architecture. Many extracellular matrix molecules are increased in MS, including chondroitin sulfate proteoglycans (CSPGs). CSPGs have potentially significant roles in MS. CSPGs are accumulated near areas of damage in MS, are capable of promoting detrimental inflammation and therefore may contribute to myelin and axon damage. My project will investigate the accumulation of CSPGs in MS. I will determine what causes their increase in MS and in the animal model of MS. I will also investigate treatments that decrease CSPG production, and determine whether these treatments can halt inflammation in MS and disease progression. My research aims to improve outcomes in this devastating and all too common disorder. Finally, while the disease interest here is MS, the clearance of non-permissive ECM is also relevant for axonal regeneration, remyelination and neurogenesis and this should impact most neurological diseases in general.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
340400
Name
Stephenson Erin
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Chondroitin sulfate proteoglycans in multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Chondroitin Sulfate Proteoglycans; Extracellular Matrix; Multiple Sclerosis; Neuroinflammation
Abstract
Multiple sclerosis is the major cause of non-traumatic neurological disability in young adults in Europe and North America. According to the Multiple Sclerosis Society of Canada website, over 100,000 Canadians are living with MS. MS impacts people in their most productive years; most people with MS have onset in their twenties and thirties. The inability of current MS therapies to halt the progression or reverse the chronic disabilities of MS emphasize the importance of developing new therapies to mitigate the abnormal immune responses and prevent irreversible disability. In MS, the protective membrane that wraps around axons in the brain and spinal, known as the myelin sheath, is destroyed by the immune system. It is currently unknown what causes immune cells to invade the brain and attack the myelin. Without the myelin sheath, axons degenerate, leading to worsening neurological disability. In MS there are also widespread changes in the extracellular matrix (ECM), a network of molecules involved in maintaining brain architecture. Many extracellular matrix molecules are increased in MS, including chondroitin sulfate proteoglycans (CSPGs). CSPGs have potentially significant roles in MS. CSPGs are accumulated near areas of damage in MS, are capable of promoting detrimental inflammation and therefore may contribute to myelin and axon damage. My project will investigate the accumulation of CSPGs in MS. I will determine what causes their increase in MS and in the animal model of MS. I will also investigate treatments that decrease CSPG production, and determine whether these treatments can halt inflammation in MS and disease progression. My research aims to improve outcomes in this devastating and all too common disorder. Finally, while the disease interest here is MS, the clearance of non-permissive ECM is also relevant for axonal regeneration, remyelination and neurogenesis and this should impact most neurological diseases in general.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Stephenson, Erin
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~